Inappropriate schedule of vaccine administered; Product origin unknown; This spontaneous report was received from a Physician via medical records (MR) regarding a case in litigation and refers to a 16-month-old female patient. The patient’s medical history, concurrent conditions, concomitant therapies were not reported. On 26-AUG-2005, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufactured unknown) administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided); which could either be measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection or measles vaccine live (schwartz), mumps vaccine live (rit 4385), rubella vaccine live (wistar ra 27/3) (PRIORIX) (Product origin unknown). On 30-JUN-2009, the patient was vaccinated with the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided); and the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufactured unknown). On 21-JUL-2009, the patient received the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) (Inappropriate schedule of product administration). This is one of the 3 cases referred to the same patient.; Sender’s Comments: US-009507513-2412USA007989: US-009507513-2501USA009376: US-009507513-2412USA007989: